Persistent organic pollutants and obesity: Are they potential mechanisms for breast cancer promotion?

Endocrine-Related Cancer

Volumn 22, Issue 2, 2015, Pages R69-R86

  Reaves, Denise K ^a   Ginsburg, Erika ^b   Bang, John J ^a   Fleming, Jodie M ^a  

^a NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Metabolism; Obesity; Persistent organic pollutants

Indexed keywords

ENDOCRINE DISRUPTOR; FAT DROPLET; POLLUTANT;

ADIPOSE TISSUE; BIOACCUMULATION; BREAST CANCER; CANCER RESEARCH; CAUSAL ATTRIBUTION; CELL FUNCTION; DIET; HORMONE ACTION; HUMAN; IN VITRO STUDY; INTRACELLULAR SIGNALING; NONHUMAN; OBESITY; PERSISTENT ORGANIC POLLUTANT; PUBLIC HEALTH; REVIEW; TUMOR GROWTH; TUMOR PROMOTION; ANIMAL; BREAST TUMOR; ENVIRONMENTAL EXPOSURE; FEMALE; METABOLISM; POLLUTANT; TOXICITY;

ADIPOSE TISSUE; ANIMALS; BREAST NEOPLASMS; DIET; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; OBESITY;

EID: 84929379153     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-14-0411     Document Type: Review

References (174)

1. Agudo A, Goni F, Etxeandia A, Vives A, Millan E, Lopez R, Amiano P, Ardanaz E, Barricarte A, Chirlaque MD et al. 2009 Polychlorinated biphenyls in Spanish adults: determinants of serum concentrations. Environmental Research 109 620-628. (doi:10.1016/j.envres.2009.03.009)
2. Airaksinen R, Rantakokko P, Eriksson JG, Blomstedt P, Kajantie E &Kiviranta H 2011 Association between type 2 diabetes and exposure to persistent organic pollutants. Diabetes Care 34 1972-1979. (doi:10.2337/dc10-2303)
3. Aroner SA, Collins LC, Schnitt SJ, Connolly JL, Colditz GA & Tamimi RM 2010 Columnar cell lesions and subsequent breast cancer risk: a nested case-control study. Breast Cancer Research 12 R61. (doi:10.1186/bcr2624)
4. Arrebola JP, Pumarega J, Gasull M, Fernandez MF, Martin-Olmedo P, Molina-Molina JM, Fernandez-Rodriguez M, Porta M & Olea N 2013 Adipose tissue concentrations of persistent organic pollutants and prevalence of type 2 diabetes in adults from Southern Spain. Environmental Research 122 31-37. (doi:10.1016/j.envres.2012.12.001)
5. Arsenescu V, Arsenescu RI, King V, Swanson H & Cassis LA 2008 Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis. Environmental Health Perspectives 116 761-768. (doi:10.1289/ehp.10554)
6. Aube M, Larochelle C & Ayotte P 2011 Differential effects of a complex organochlorine mixture on the proliferation of breast cancer cell lines. Environmental Research 111 337-347. (doi:10.1016/j.envres.2011.01.010)
7. Baillie-Hamilton PF 2002 Chemical toxins: a hypothesis to explain the global obesity epidemic. Journal of Alternative and Complementary Medicine 8 185-192. (doi:10.1089/107555302317371479)
8. Barber MC, Clegg RA, Travers MT & Vernon RG 1997 Lipid metabolism in the lactating mammary gland. Biochimica et Biophysica Acta 1347 101-126. (doi:10.1016/S0005-2760(97)00079-9)
9. Baumann J, Sevinsky C & Conklin DS 2013 Lipid biology of breast cancer. Biochimica et Biophysica Acta 1831 1509-1517. (doi:10.1016/j.bbalip.2013.03.011)
10. Beischlag TV, Luis Morales J, Hollingshead BD & Perdew GH 2008 The aryl hydrocarbon receptor complex and the control of gene expression. Critical Reviews in Eukaryotic Gene Expression 18 207-250. (doi:10.1615/CritRevEukarGeneExpr.v18.i3.20)
11. Berndt J, Kovacs P, Ruschke K, Kloting N, Fasshauer M, Schon MR, Korner A, Stumvoll M & Bluher M 2007 Fatty acid synthase gene expression in human adipose tissue: association with obesity and type 2 diabetes. Diabetologia 50 1472-1480. (doi:10.1007/s00125-007-0689-x)
12. Bhurosy T & Jeewon R 2013 Food habits, socioeconomic status and body mass index among premenopausal and post-menopausal women in Mauritius. Journal of Human Nutrition and Dietetics 26 (Suppl 1)114-122. (doi:10.1111/jhn.12100)
13. Bhurosy T & Jeewon R 2014 Overweight and obesity epidemic in developing countries: a problem with diet, physical activity, or socioeconomic status? ScientificWorldJournal 2014 964236. (doi:10.1155/2014/964236)
14. Bloor ID & Symonds ME 2014 Sexual dimorphism in white and brown adipose tissue with obesity and inflammation. Hormones and Behavior 66 95-103. (doi:10.1016/j.yhbeh.2014.02.007)
15. Bonefeld-Jorgensen EC, Long M, Bossi R, Ayotte P, Asmund G, Kruger T, Ghisari M, Mulvad G, Kern P, Nzulumiki P et al. 2011 Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: a case control study. Environmental Health 10 88. (doi:10.1186/1476-069X-10-88)
16. Bonefeld-Jørgensen EC, Ghisari M, Wielsøe M, Bjerregaard-Olesen C, Kjeldsen LS & Long M 2014 Biomonitoring and hormone-disrupting effect biomarkers of persistent organic pollutants in vitro and ex vivo. Basic & Clinical Pharmacology & Toxicology 115 118-128. (doi:10.1111/bcpt.12263)
17. Bourdon JA, Bazinet TM, Arnason TT, Kimpe LE, Blais JM & White PA 2010 Polychlorinated biphenyls (PCBs) contamination and aryl hydrocarbon receptor (AhR) agonist activity of Omega-3 polyunsaturated fatty acid supplements: implications for daily intake of dioxins and PCBs. Food and Chemical Toxicology 48 3093-3097. (doi:10.1016/j.fct.2010.07.051)
18. Bourez S, Le Lay S, Van den Daelen C, Louis C, Larondelle Y, Thome JP, Schneider YJ, Dugail I & Debier C 2012 Accumulation of polychlorinated biphenyls in adipocytes: selective targeting to lipid droplets and role of caveolin-1. PLoS ONE 7 e31834. (doi:10.1371/journal.pone.0031834)
19. Bourez S, Van den Daelen C, Le Lay S, Poupaert J, Larondelle Y, Thome JP, Schneider YJ, Dugail I & Debier C 2013 The dynamics of accumulation of PCBs in cultured adipocytes vary with the cell lipid content and the lipophilicity of the congener. Toxicology Letters 216 40-46. (doi:10.1016/j.toxlet.2012.09.027)
20. Boyle P 2012 Triple-negative breast cancer: epidemiological considerations and recommendations. Annals of Oncology 23 (Suppl 6) vi7-v12. (doi:10.1093/annonc/mds187)
21. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, Fraser G, Goldbohm RA, Graham S, Kushi L et al. 2000 Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. American Journal of Epidemiology 152 514-527. (doi:10.1093/aje/152.6.514)
22. Butt CM, Berger U, Bossi R & Tomy GT 2010 Levels and trends of poly- and perfluorinated compounds in the arctic environment. Science of the Total Environment 408 2936-2965. (doi:10.1016/j.scitotenv.2010.03.015)
23. Caballero B 2007 The global epidemic of obesity: an overview. Epidemiologic Reviews 29 1-5. (doi:10.1093/epirev/mxm012)
24. Cabaravdic M 2006 Xenoestrogen effects of chemical compounds: influence on the breast cancer. Medical Archives 60 97-100.
25. Capasso I, Esposito E, de Laurentiis M, Maurea N, Cavalcanti E, Botti G, Petrillo A, Montella M, D'Aiuto M, Coppola C et al. 2014 Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype. Diabetology & Metabolic Syndrome 6 105. (doi:10.1186/1758-5996-6-105)
26. Caprio S, Daniels SR, Drewnowski A, Kaufman FR, Palinkas LA, Rosenbloom AL & Schwimmer JB 2008a Influence of race, ethnicity, and culture on childhood obesity: implications for prevention and treatment. Obesity 16 2566-2577. (doi:10.1038/oby.2008.398)
27. Caprio S, Daniels SR, Drewnowski A, Kaufman FR, Palinkas LA, Rosenbloom AL & Schwimmer JB 2008b Influence of race, ethnicity, and culture on childhood obesity: implications for prevention and treatment: a consensus statement of Shaping America's Health and the Obesity Society. Diabetes Care 31 2211-2221. (doi:10.2337/dc08-9024)
28. Carriot J, Jamali M, Chacron MJ & Cullen KE 2014 Statistics of the vestibular input experienced during natural self-motion: implications for neural processing. Journal of Neuroscience 34 8347-8357. (doi:10.1523/JNEUROSCI.0692-14.2014)
29. Casbas-Hernandez P, Fleming JM & Troester MA 2011 Gene expression analysis of in vitro cocultures to study interactions between breast epithelium and stroma. Journal of Biomedicine & Biotechnology 2011 520987. (doi:10.1155/2011/520987)
30. Casbas-Hernandez P, Sun X, Roman-Perez E, D'Arcy M, Sandhu R, Hishida A, McNaughton KK, Yang XR, Makowski L, Sherman ME et al. 2014 Tumor intrinsic subtype is reflected in cancer-adjacent tissue. Cancer Epidemiology, Biomarkers & Prevention (In Press). (doi:10.1158/1055-9965.EPI-14-0934)
31. Chan PC, Head JF, Cohen LA & Wynder EL 1977 Influence of dietary fat on the induction of mammary tumors by N-nitrosomethylurea: associated hormone changes and differences between Sprague-Dawley and F344 rats. Journal of the National Cancer Institute 59 1279-1283. (doi:10.1093/jnci/59.4.1279)
32. Chandran U, Hirshfield KM & Bandera EV 2012 The role of anthropometric and nutritional factors on breast cancer risk in African-American women. Public Health Nutrition 15 738-748. (doi:10.1017/S136898001100303X)
33. Chen Y, Krishan M, Nebert DW & Shertzer HG 2012 Glutathione-deficient mice are susceptible to TCDD-induced hepatocellular toxicity but resistant to steatosis. Chemical Research in Toxicology 25 94-100. (doi:10.1021/tx200242a)
34. Chung JH, Seo AY, Chung SW, Kim MK, Leeuwenburgh C, Yu BP & Chung HY 2008 Molecular mechanism of PPAR in the regulation of age-related inflammation. Ageing Research Reviews 7 126-136. (doi:10.1016/j.arr.2008.01.001)
35. Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA & Schnitt SJ 2006 The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study. Cancer 107 1240-1247. (doi:10.1002/cncr.22136)
36. Conklin DJ, Barski OA, Lesgards JF, Juvan P, Rezen T, Rozman D, Prough RA, Vladykovskaya E, Liu S, Srivastava S et al. 2010 Acrolein consumption induces systemic dyslipidemia and lipoprotein modification. Toxicology and Applied Pharmacology 243 1-12. (doi:10.1016/j.taap.2009.12.010)
37. Corsini E, Luebke RW, Germolec DR & DeWitt JC 2014 Perfluorinated compounds: emerging POPs with potential immunotoxicity. Toxicology Letters 230 263-270. (doi:10.1016/j.toxlet.2014.01.038)
38. De Assis S & Hilakivi-Clarke L 2006 Timing of dietary estrogenic exposures and breast cancer risk. Annals of the New York Academy of Sciences 1089 14-35. (doi:10.1196/annals.1386.039)
39. Decherf S & Demeneix BA 2011 The obesogen hypothesis: a shift of focus from the periphery to the hypothalamus. Journal of Toxicology and Environmental Health. Part B, Critical Reviews 14 423-448. (doi:10.1080/10937404.2011.578561)
40. Delort L, Lequeux C, Dubois V, Dubouloz A, Billard H, Mojallal A, Damour O, Vasson MP & Caldefie-Chezet F 2013 Reciprocal interactions between breast tumor and its adipose microenvironment based on a 3D adipose equivalent model. PLoS ONE 8 e66284. (doi:10.1371/journal.pone.0066284)
41. De Pergola G & Silvestris F 2013 Obesity as a major risk factor for cancer. Journal of Obesity 2013 291546. (doi:10.1155/2013/291546)
42. DeSantis C, Ma J, Bryan L & Jemal A 2014 Breast cancer statistics, 2013. CA: A Cancer Journal for Clinicians 64 52-62. (doi:10.3322/caac.21203)
43. DeWitt JC, Peden-Adams MM, Keller JM & Germolec DR 2012 Immunotoxicity of perfluorinated compounds: recent developments. Toxicologic Pathology 40 300-311. (doi:10.1177/0192623311428473)
44. Dirinck E, Jorens PG, Covaci A, Geens T, Roosens L, Neels H, Mertens I &Van Gaal L 2011 Obesity and persistent organic pollutants: possible obesogenic effect of organochlorine pesticides and polychlorinated biphenyls. Obesity 19 709-714. (doi:10.1038/oby.2010.133)
45. Domingo JL 2012 Health risks of dietary exposure to perfluorinated compounds. Environment International 40 187-195. (doi:10.1016/j.envint.2011.08.001)
46. Duggan C, Irwin ML, Xiao L, Henderson KD, Smith AW, Baumgartner RN, Baumgartner KB, Bernstein L, Ballard-Barbash R & McTiernan A 2011 Associations of insulin resistance and adiponectin with mortality in women with breast cancer. Journal of Clinical Oncology 29 32-39. (doi:10.1200/JCO.2009.26.4473)
47. Dunneram Y & Jeewon R 2013 A scientific assessment of sociodemographic factors, physical activity level, and nutritional knowledge as determinants of dietary quality among Indo-Mauritian women. Journal of Nutrition and Metabolism 2013 572132. (doi:10.1155/2013/572132)
48. Dunnwald LK, Rossing MA & Li CI 2007 Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Research 9 R6. (doi:10.1186/bcr1639)
49. Fleming JM, Long EL, Ginsburg E, Gerscovich D, Meltzer PS & Vonderhaar BK 2008 Interlobular and intralobular mammary stroma: genotype may not reflect phenotype. BMC Cell Biology 9 46. (doi:10.1186/1471-2121-9-46)
50. Fokeena WB & Jeewon R 2012 Is there an association between socioeconomic status and body mass index among adolescents in Mauritius? Scientific World Journal 2012 750659. (doi:10.1100/2012/750659)
51. Freire C, Amaya E, Fernandez MF, Gonzalez-Galarzo MC, Ramos R, Molina-Molina JM, Arrebola JP & Olea N 2011 Relationship between occupational social class and exposure to organochlorine pesticides during pregnancy. Chemosphere 83 831-838. (doi:10.1016/j.chemosphere.2011.02.076)
52. Gadupudi G, Gourronc FA, Ludewig G, Robertson LW & Klingelhutz AJ 2014 PCB126 inhibits adipogenesis of human preadipocytes. Toxicology in Vitro 29 132-141. (doi:10.1016/j.tiv.2014.09.015)
53. Gasull M, Pumarega J, Rovira G, Lopez T, Alguacil J & Porta M 2013 Relative effects of educational level and occupational social class on body concentrations of persistent organic pollutants in a representative sample of the general population of Catalonia, Spain. Environment International 60 190-201. (doi:10.1016/j.envint.2013.08.001)
54. Gilsanz V, Hu HH & Kajimura S 2013 Relevance of brown adipose tissue in infancy and adolescence. Pediatric Research 73 3-9. (doi:10.1038/pr.2012.141)
55. Giordano A, Smorlesi A, Frontini A, Barbatelli G & Cinti S 2014 White, brown and pink adipocytes: the extraordinary plasticity of the adipose organ. European Journal of Endocrinology 170 R159-R171. (doi:10.1530/EJE-13-0945)
56. Giralt M & Villarroya F 2013 White, brown, beige/brite: different adipose cells for different functions? Endocrinology 154 2992-3000. (doi:10.1210/en.2013-1403)
57. Green B & Duffull SB 2004 What is the best size descriptor to use for pharmacokinetic studies in the obese? British Journal of Clinical Pharmacology 58 119-133. (doi:10.1111/j.1365-2125.2004.02157.x)
58. Grun F & Blumberg B 2006 Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147 S50-S55. (doi:10.1210/en.2005-1129)
59. Gutleb AC, Freitas J, Murk AJ, Verhaegen S, Ropstad E, Udelhoven T, Hoffmann L & Audinot JN 2012 NanoSIMS50 - a powerful tool to elucidate cellular localization of halogenated organic compounds. Analytical and Bioanalytical Chemistry 404 2693-2698. (doi:10.1007/s00216-012-6066-8)
60. Hakkak R, Holley AW, Macleod SL, Simpson PM, Fuchs GJ, Jo CH, Kieber-Emmons T & Korourian S 2005 Obesity promotes 7,12-dimethylbenz(a) anthracene-induced mammary tumor development in female Zucker rats. Breast Cancer Research 7 R627-R633. (doi:10.1186/bcr1263)
61. Hakkak R, MacLeod S, Shaaf S, Holley AW, Simpson P, Fuchs G, Jo CH, Kieber-Emmons T & Korourian S 2007 Obesity increases the incidence of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in an ovariectomized Zucker rat model. International Journal of Oncology 30 557-563. (doi:10.3892/ijo.30.3.557)
62. Ham M & Moon A 2013 Inflammatory and microenvironmental factors involved in breast cancer progression. Archives of Pharmacal Research 36 1419-1431. (doi:10.1007/s12272-013-0271-7)
63. Harvey AE, Lashinger LM & Hursting SD 2011 The growing challenge of obesity and cancer: an inflammatory issue. Annals of the New York Academy of Sciences 1229 45-52. (doi:10.1111/j.1749-6632.2011.06096.x)
64. Hassiotou F & Geddes D 2013 Anatomy of the human mammary gland: current status of knowledge. Clinical Anatomy 26 29-48. (doi:10.1002/ca.22165)
65. Hebert JR, Wirth M, Davis L, Davis B, Harmon BE, Hurley TG, Drayton R, Angela Murphy E, Shivappa N, Wilcox S et al. 2013 C-reactive protein levels in African Americans: a diet and lifestyle randomized community trial. American Journal of Preventive Medicine 45 430-440. (doi:10.1016/j.amepre.2013.05.011)
66. Hernandez F, Portoles T, Pitarch E & Lopez FJ 2009 Searching for anthropogenic contaminants in human breast adipose tissues using gas chromatography-time-of-flight mass spectrometry. Journal of Mass Spectrometry 44 1-11. (doi:10.1002/jms.1538)
67. Hilakivi-Clarke L & de Assis S 2006 Fetal origins of breast cancer. Trends in Endocrinology and Metabolism 17 340-348. (doi:10.1016/j.tem.2006.09.002)
68. Hilakivi-Clarke L, Wang C, Kalil M, Riggins R & Pestell RG 2004 Nutritional modulation of the cell cycle and breast cancer. Endocrine-Related Cancer 11 603-622. (doi:10.1677/erc.1.00665)
69. Hilakivi-Clarke L, Luoto R, Huttunen T & Koskenvuo M 2005 Pregnancy weight gain and premenopausal breast cancer risk. Journal of Reproductive Medicine 50 811-816.
70. Hilvo M, Denkert C, Lehtinen L, Muller B, Brockmoller S, Seppanen-Laakso T, Budczies J, Bucher E, Yetukuri L, Castillo S et al. 2011 Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. Cancer Research 71 3236-3245. (doi:10.1158/0008-5472.CAN-10-3894)
71. Hopperton KE, Duncan RE, Bazinet RP & Archer MC 2014 Fatty acid synthase plays a role in cancer metabolism beyond providing fatty acids for phospholipid synthesis or sustaining elevations in glycolytic activity. Experimental Cell Research 320 302-310. (doi:10.1016/j.yexcr.2013.10.016)
72. Hovey RC, Trott JF & Vonderhaar BK 2002 Establishing a framework for the functional mammary gland: from endocrinology to morphology. Journal of Mammary Gland Biology and Neoplasia 7 17-38. (doi:10.1023/A:1015766322258)
73. Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE, Hennekens CH, Rosner B, Speizer FE & Willett WC 1997 Dual effects of weight and weight gain on breast cancer risk. Journal of the American Medical Association 278 1407-1411. (doi:10.1001/jama.1997.03550170037029)
74. Hunt DA, Lane HM, Zygmont ME, Dervan PA & Hennigar RA 2007 mRNA stability and overexpression of fatty acid synthase in human breast cancer cell lines. Anticancer Research 27 27-34.
75. Hwang MS, Yu N, Stinson SY, Yue P, Newman RJ, Allan BB & Dornan D 2013 miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to-mesenchymal transition in breast cancer. PLoS ONE 8 e66502. (doi:10.1371/journal.pone.0066502)
76. Ibarguren M, Lopez DJ & Escriba PV 2014 The effect of natural and synthetic fatty acids on membrane structure, microdomain organization, cellular functions and human health. Biochimica et Biophysica Acta 1838 1518-1528. (doi:10.1016/j.bbamem.2013.12.021)
77. Jemal A, Siegel R, Ward E, Murray T, Xu J & Thun MJ 2007 Cancer statistics, 2007. CA: A Cancer Journal for Clinicians 57 43-66. (doi:10.3322/canjclin.57.1.43)
78. Jones PD, Hu W, De Coen W, Newsted JL & Giesy JP 2003 Binding of perfluorinated fatty acids to serum proteins. Environmental Toxicology and Chemistry 22 2639-2649. (doi:10.1897/02-553)
79. Karastergiou K, Smith SR, Greenberg AS & Fried SK 2012 Sex differences in human adipose tissues - the biology of pear shape. Biology of Sex Differences 3 13. (doi:10.1186/2042-6410-3-13)
80. Kerley-Hamilton JS, Trask HW, Ridley CJ, Dufour E, Ringelberg CS, Nurinova N, Wong D, Moodie KL, Shipman SL, Moore JH et al. 2012 Obesity is mediated by differential aryl hydrocarbon receptor signaling in mice fed a Western diet. Environmental Health Perspectives 120 1252-1259. (doi:10.1289/ehp.1205003)
81. Khan A, Aljarbou AN, Aldebasi YH, Faisal SM & Khan MA 2014 Resveratrol suppresses the proliferation of breast cancer cells by inhibiting fatty acid synthase signaling pathway. Cancer Epidemiology 38 765-772. (doi:10.1016/j.canep.2014.09.006)
82. Kim KY, Kim DS, Lee SK, Lee IK, Kang JH, Chang YS, Jacobs DR, Steffes M &Lee DH 2010 Association of low-dose exposure to persistent organic pollutants with global DNA hypomethylation in healthy Koreans. Environmental Health Perspectives 118 370-374. (doi:10.1289/ehp.0901131)
83. Kim MJ, Pelloux V, Guyot E, Tordjman J, Bui LC, Chevallier A, Forest C, Benelli C, Clement K & Barouki R 2012 Inflammatory pathway genes belong to major targets of persistent organic pollutants in adipose cells. Environmental Health Perspectives 120 508-514. (doi:10.1289/ehp.1104282)
84. Kim BM, Rhee JS, Hwang UK, Seo JS, Shin KH & Lee JS 2014 Dose- and time-dependent expression of aryl hydrocarbon receptor (AhR) and aryl hydrocarbon receptor nuclear translocator (ARNT) in PCB-, B[a]P-, and TBT-exposed intertidal copepod Tigriopus japonicus. Chemosphere 120C 398-406. (doi:10.1016/j.chemosphere.2014.07.099)
85. Kuemmerle NB, Rysman E, Lombardo PS, Flanagan AJ, Lipe BC, Wells WA, Pettus JR, Froehlich HM, Memoli VA, Morganelli PM et al. 2011 Lipoprotein lipase links dietary fat to solid tumor cell proliferation. Molecular Cancer Therapeutics 10 427-436. (doi:10.1158/1535-7163.MCT-10-0802)
86. La Merrill M, Emond C, Kim MJ, Antignac JP, Le Bizec B, Clement K, Birnbaum LS & Barouki R 2013 Toxicological function of adipose tissue: focus on persistent organic pollutants. Environmental Health Perspectives 121 162-169. (doi:10.1289/ehp.1205485)
87. Lara LA, Duarte AA, Reis RM, Vieira CS & Rosa-e-Silva AC 2012 Endocrine disrupters: potential risk factors affecting sexual function in both men and women. Journal of Sexual Medicine 9 941-942. (doi:10.1111/j.1743-6109.2011.02596.x)
88. Lautenbach A, Budde A, Wrann CD, Teichmann B, Vieten G, Karl T & Nave H 2009 Obesity and the associated mediators leptin, estrogen and IGF-I enhance the cell proliferation and early tumorigenesis of breast cancer cells. Nutrition and Cancer 61 484-491. (doi:10.1080/01635580802610115)
89. Lee DH, Steffes MW, Sjodin A, Jones RS, Needham LL & Jacobs DR Jr 2010 Low dose of some persistent organic pollutants predicts type 2 diabetes: a nested case-control study. Environmental Health Perspectives 118 1235-1242. (doi:10.1289/ehp.0901480)
90. Lemaire G, Mnif W, Mauvais P, Balaguer P & Rahmani R 2006 Activation of α- and β-estrogen receptors by persistent pesticides in reporter cell lines. Life Sciences 79 1160-1169. (doi:10.1016/j.lfs.2006.03.023)
91. Letcher RJ, Bustnes JO, Dietz R, Jenssen BM, Jorgensen EH, Sonne C, Verreault J, Vijayan MM & Gabrielsen GW 2010 Exposure and effects assessment of persistent organohalogen contaminants in arctic wildlife and fish. Science of the Total Environment 408 2995-3043. (doi:10.1016/j.scitotenv.2009.10.038)
92. Ljunggren SA, Helmfrid I, Salihovic S, van Bavel B, Wingren G, Lindahl M &Karlsson H 2014 Persistent organic pollutants distribution in lipoprotein fractions in relation to cardiovascular disease and cancer. Environment International 65 93-99. (doi:10.1016/j.envint.2013.12.017)
93. Lv Z, Li G, Li Y, Ying C, Chen J, Chen T, Wei J, Lin Y, Jiang Y, Wang Y et al. 2013 Glucose and lipid homeostasis in adult rat is impaired by early-life exposure to perfluorooctane sulfonate. Environmental Toxicology 28 532-542. (doi:10.1002/tox.20747)
94. Mackenbach JP, Stirbu I, Roskam AJ, Schaap MM, Menvielle G, Leinsalu M & Kunst AE 2008 Socioeconomic inequalities in health in 22 European countries. New England Journal of Medicine 358 2468-2481. (doi:10.1056/NEJMsa0707519)
95. Magliano DJ, Loh VH, Harding JL, Botton J & Shaw JE 2014 Persistent organic pollutants and diabetes: a review of the epidemiological evidence. Diabetes & Metabolism 40 1-14. (doi:10.1016/j.diabet.2013.09.006)
96. Matsuda M & Shimomura I 2013 Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obesity Research & Clinical Practice 7 e330-e341. (doi:10.1016/j.orcp.2013.05.004)
97. McManaman JL 2014 Lipid transport in the lactating mammary gland. Journal of Mammary Gland Biology and Neoplasia 19 35-42. (doi:10.1007/s10911-014-9318-8)
98. Medina CM, Pitarch E, Portoles T, Lopez FJ & Hernandez F 2009 GC-MS/MS multi-residue method for the determination of organochlorine pesticides, polychlorinated biphenyls and polybrominated diphenyl ethers in human breast tissues. Journal of Separation Science 32 2090-2102. (doi:10.1002/jssc.200800737)
99. Meeker JD 2012 Exposure to environmental endocrine disruptors and child development. Archives of Pediatrics & Adolescent Medicine 166 E1-E7. (doi:10.1001/archpediatrics.2012.241)
100. Murray MJ, Saini HK, van Dongen S, Palmer RD, Muralidhar B, Pett MR, Piipari M, Thornton CM, Nicholson JC, Enright AJ et al. 2010 The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expression. Molecular Cancer 9 290. (doi:10.1186/1476-4598-9-290)
101. Myre M & Imbeault P 2014 Persistent organic pollutants meet adipose tissue hypoxia: does cross-talk contribute to inflammation during obesity? Obesity Reviews 15 19-28. (doi:10.1111/obr.12086)
102. Nalabolu MR, Palasamudram K & Jamil K 2014 Adiponectin and leptin molecular actions and clinical significance in breast cancer. International Journal of Hematology-Oncology and Stem Cell Research 8 31-40.
103. Newman LA, Mason J, Cote D, Vin Y, Carolin K, Bouwman D & Colditz GA 2002 African-American ethnicity, socioeconomic status, and breast cancer survival: a meta-analysis of 14 studies involving over 10,000 African-American and 40,000 White American patients with carcinoma of the breast. Cancer 94 2844-2854. (doi:10.1002/cncr.10575)
104. Nguyen DH, Fredlund E, Zhao W, Perou CM, Balmain A, Mao JH &Barcellos-Hoff MH 2013 Murine microenvironment metaprofiles associate with human cancer etiology and intrinsic subtypes. Clinical Cancer Research 19 1353-1362. (doi:10.1158/1078-0432.CCR-12-3554)
105. Nielsen NH & Hansen JP 1980 Breast cancer in Greenland - selected epidemiological, clinical, and histological features. Journal of Cancer Research and Clinical Oncology 98 287-299. (doi:10.1007/BF00410791)
106. Noyes PD, McElwee MK, Miller HD, Clark BW, Van Tiem LA, Walcott KC, Erwin KN & Levin ED 2009 The toxicology of climate change: environmental contaminants in a warming world. Environment International 35 971-986. (doi:10.1016/j.envint.2009.02.006)
107. de Oliveira Andrade F, Fontelles CC, Rosim MP, de Oliveira TF, de Melo Loureiro AP, Mancini-Filho J, Rogero MM, Moreno FS, de Assis S, Barbisan LF et al. 2014 Exposure to lard-based high-fat diet during fetal and lactation periods modifies breast cancer susceptibility in adulthood in rats. Journal of Nutritional Biochemistry 25 613-622. (doi:10.1016/j.jnutbio.2014.02.002)
108. Park J, Morley TS, Kim M, Clegg DJ & Scherer PE 2014a Obesity and cancer - mechanisms underlying tumour progression and recurrence. Nature Reviews. Endocrinology 10 455-465. (doi:10.1038/nrendo.2014.94)
109. Park J, Cho SY, Lee SB, Son H & Jeong H 2014b Obesity is associated with higher risk of prostate cancer detection in a biopsy population in Korea. BJU International 114 891-895. (doi:10.1111/bju.12600)
110. Parmar H & Cunha GR 2004 Epithelial-stromal interactions in the mouse and human mammary gland in vivo. Endocrine-Related Cancer 11 437-458. (doi:10.1677/erc.1.00659)
111. Pavlovich AL, Manivannan S & Nelson CM 2010 Adipose stroma induces branching morphogenesis of engineered epithelial tubules. Tissue Engineering. Part A 16 3719-3726. (doi:10.1089/ten.tea.2009.0836)
112. Pereira-Fernandes A, Dirinck E, Dirtu AC, Malarvannan G, Covaci A, Van Gaal L, Vanparys C, Jorens PG & Blust R 2014 Expression of obesity markers and Persistent Organic Pollutants levels in adipose tissue of obese patients: reinforcing the obesogen hypothesis? PLoS ONE 9 e84816. (doi:10.1371/journal.pone.0084816)
113. Pestana D, Faria G, Sa C, Fernandes VC, Teixeira D, Norberto S, Faria A, Meireles M, Marques C, Correia-Sa L et al. 2014 Persistent organic pollutant levels in human visceral and subcutaneous adipose tissue in obese individuals - depot differences and dysmetabolism implications. Environmental Research 133 170-177. (doi:10.1016/j.envres.2014.05.026)
114. Petreas M, Smith D, Hurley S, Jeffrey SS, Gilliss D & Reynolds P 2004 Distribution of persistent, lipid-soluble chemicals in breast and abdominal adipose tissues: lessons learned from a breast cancer study. Cancer Epidemiology, Biomarkers & Prevention 13 416-424.
115. Petreas M, Nelson D, Brown FR, Goldberg D, Hurley S & Reynolds P 2011 High concentrations of polybrominated diphenylethers (PBDEs) in breast adipose tissue of California women. Environment International 37 190-197. (doi:10.1016/j.envint.2010.09.001)
116. Pham do Q, Ommerborn MJ, Hickson DA, Taylor HA & Clark CR 2014 Neighborhood safety and adipose tissue distribution in African Americans: the Jackson Heart Study. PLoS ONE 9 e105251. (doi:10.1371/journal.pone.0105251)
117. Planey SL, Kumar R & Arnott JA 2014 Estrogen receptors (ERa versus ERb): friends or foes in human biology? Journal of Receptor and Signal Transduction Research 34 1-5. (doi:10.3109/10799893.2013.853188)
118. Pombo M & Castro-Feijoo L 2005 Endocrine disruptors. Journal of Pediatric Endocrinology & Metabolism 18 (Suppl 1) 1145-1155. (doi:10.1515/JPEM.2005.18.S1.1145)
119. Popkin BM, Adair LS & Ng SW 2012 Global nutrition transition and the pandemic of obesity in developing countries. Nutrition Reviews 70 3-21. (doi:10.1111/j.1753-4887.2011.00456.x)
120. Prieto-Hontoria PL, Perez-Matute P, Fernandez-Galilea M, Bustos M, Martinez JA & Moreno-Aliaga MJ 2011 Role of obesity-associated dysfunctional adipose tissue in cancer: a molecular nutrition approach. Biochimica et Biophysica Acta 1807 664-678. (doi:10.1016/j.bbabio.2010.11.004)
121. Priyanka HP, Sharma U, Gopinath S, Sharma V, Hima L & ThyagaRajan S 2013 Menstrual cycle and reproductive aging alters immune reactivity, NGF expression, antioxidant enzyme activities, and intracellular signaling pathways in the peripheral blood mononuclear cells of healthy women. Brain, Behavior, and Immunity 32 131-143. (doi:10.1016/j.bbi.2013.03.008)
122. Proia DA & Kuperwasser C 2006 Reconstruction of human mammary tissues in a mouse model. Nature Protocols 1 206-214. (doi:10.1038/nprot.2006.31)
123. Protani M, Coory M & Martin JH 2010 Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Research and Treatment 123 627-635. (doi:10.1007/s10549-010-0990-0)
124. Puig T, Porta R & Colomer R 2009 Fatty acid synthase: a new anti-tumor target. Medicina Clínica 132 359-363. (doi:10.1016/j.medcli.2008.07.022)
125. Reynolds P, Hurley SE, Petreas M, Goldberg DE, Smith D, Gilliss D, Mahoney ME & Jeffrey SS 2005 Adipose levels of dioxins and risk of breast cancer. Cancer Causes Control 16 525-535. (doi:10.1007/s10552-004-7840-5)
126. Richmond A & Su Y 2008 Mouse xenograft models vs GEM models for human cancer therapeutics. Disease Models & Mechanisms 1 78-82. (doi:10.1242/dmm.000976)
127. Ritter L, Solomon K, Sibley P, Hall K, Keen P, Mattu G & Linton B 2002 Sources, pathways, and relative risks of contaminants in surface water and groundwater: a perspective prepared for the Walkerton inquiry. Journal of Toxicology and Environmental Health. Part A 65 1-142. (doi:10.1080/152873902753338572)
128. Romero-Figueroa Mdel S, Garduno-Garcia Jde J, Duarte-Mote J, Matute-Gonzalez G, Gomez-Villanueva A & De la Cruz-Vargas J 2013 Insulin and leptin levels in obese patients with and without breast cancer. Clinical Breast Cancer 13 482-485. (doi:10.1016/j.clbc.2013.08.001)
129. Roos V, Ronn M, Salihovic S, Lind L, van Bavel B, Kullberg J, Johansson L, Ahlstrom H & Lind PM 2013 Circulating levels of persistent organic pollutants in relation to visceral and subcutaneous adipose tissue by abdominal MRI. Obesity 21 413-418. (doi:10.1002/oby.20267)
130. Rose DP & Vona-Davis L 2014 Biochemical and molecular mechanisms for the association between obesity, chronic inflammation, and breast cancer. BioFactors 40 1-12. (doi:10.1002/biof.1109)
131. Rosenwald M & Wolfrum C 2014 The origin and definition of brite versus white and classical brown adipocytes. Adipocyte 3 4-9. (doi:10.4161/adip.26232)
132. Russo J 1983 Basis of cellular autonomy in the susceptibility to carcinogenesis. Toxicologic Pathology 11 149-166. (doi:10.1177/019262338301100207)
133. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR & van Zwieten MJ 1990 Comparative study of human and rat mammary tumorigenesis. Laboratory Investigation 62 244-278. (doi:10.1007/978-1-4612-0485-5-15)
134. Ruzzin J, Petersen R, Meugnier E, Madsen L, Lock EJ, Lillefosse H, Ma T, Pesenti S, Sonne SB, Marstrand TT et al. 2010 Persistent organic pollutant exposure leads to insulin resistance syndrome. Environmental Health Perspectives 118 465-471. (doi:10.1289/ehp.0901321)
135. Rylander L, Rignell-Hydbom A, Tinnerberg H & Jonsson BA 2014 Trends in human concentrations of endocrine disruptors: possible reasons and consequences. Journal of Epidemiology and Community Health 68 4-5. (doi:10.1136/jech-2012-201508)
136. Salameh TS, Le TT, Nichols MB, Bauer E, Cheng J & Camarillo IG 2013 An ex vivo co-culture model system to evaluate stromal-epithelial interactions in breast cancer. International Journal of Cancer 132 288-296. (doi:10.1002/ijc.27672)
137. Salisbury TB, Morris GZ, Tomblin JK, Chaudhry AR, Cook CR & Santanam N 2013 Aryl hydrocarbon receptor ligands inhibit IGF-II and adipokine stimulated breast cancer cell proliferation. ISRN Endocrinology 2013 104850. (doi:10.1155/2013/104850)
138. Sanders J & Samuelson DJ 2014 Significant overlap between human genome-wide association-study nominated breast cancer risk alleles and rat mammary cancer susceptibility loci. Breast Cancer Research 16 R14. (doi:10.1186/bcr3607)
139. Santen RJ, Yue W & Wang JP 2014 Estrogen metabolites and breast cancer. Steroids (In Press). (doi:10.1016/j.steroids.2014.08.003)
140. Saxena NK & Sharma D 2010 Metastasis suppression by adiponectin: LKB1 rises up to the challenge. Cell Adhesion & Migration 4 358-362. (doi:10.4161/cam.4.3.11541)
141. Saxena NK, Taliaferro-Smith L, Knight BB, Merlin D, Anania FA, O'Regan RM & Sharma D 2008 Bidirectional crosstalk between leptin and insulinlike growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor. Cancer Research 68 9712-9722. (doi:10.1158/0008-5472.CAN-08-1952)
142. Schnitt SJ 2001 Benign breast disease and breast cancer risk: potential role for antiestrogens. Clinical Cancer Research 7 4419s-4422s discussion 4411s-4412s.
143. Schwab U, Lauritzen L, Tholstrup T, Haldorssoni T, Riserus U, Uusitupa M & Becker W 2014 Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic review. Food &Nutrition Research 58 24145. (doi:10.3402/fnr.v58.25145)
144. Seale P & Lazar MA 2009 Brown fat in humans: turning up the heat on obesity. Diabetes 58 1482-1484. (doi:10.2337/db09-0622)
145. Seale P, Kajimura S & Spiegelman BM 2009 Transcriptional control of brown adipocyte development and physiological function - of mice and men. Genes and Development 23 788-797. (doi:10.1101/gad.1779209)
146. Shan Q, Wang J, Huang F, Lv X, Ma M & Du Y 2014 Augmented atherogenesis in ApoE-null mice co-exposed to polychlorinated biphenyls and 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology 276 136-146. (doi:10.1016/j.taap.2014.02.007)
147. Shepel LA & Gould MN 1999 The genetic components of susceptibility to breast cancer in the rat. Progress in Experimental Tumor Research 35 158-169. (doi:10.1159/000062012)
148. Shoushtari AN, Michalowska AM & Green JE 2007 Comparing genetically engineered mouse mammary cancer models with human breast cancer by expression profiling. Breast Disease 28 39-51.
149. Siddiqui RA, Harvey KA, Zaloga GP & Stillwell W 2007 Modulation of lipid rafts by Ω-3 fatty acids in inflammation and cancer: implications for use of lipids during nutrition support. Nutrition in Clinical Practice 22 74-88. (doi:10.1177/011542650702200174)
150. Simpson ER 2003 Sources of estrogen and their importance. Journal of Steroid Biochemistry and Molecular Biology 86 225-230. (doi:10.1016/S0960-0760(03)00360-1)
151. Solomon GM & Schettler T 2000 Environment and health: 6. Endocrine disruption and potential human health implications. CMAJ: Canadian Medical Association Journal 163 1471-1476.
152. Sonne C 2010 Health effects from long-range transported contaminants in Arctic top predators: an integrated review based on studies of polar bears and relevant model species. Environment International 36 461-491. (doi:10.1016/j.envint.2010.03.002)
153. Sorlie T, Perou CM, Tibshirani R, Aas T, GeislerS, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS et al. 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. PNAS 98 10869-10874. (doi:10.1073/pnas.191367098)
154. Stephenson GD & Rose DP 2003 Breast cancer and obesity: an update. Nutrition and Cancer 45 1-16. (doi:10.1207/S15327914NC4501-1)
155. Suba Z 2013 Circulatory estrogen level protects against breast cancer in obese women. Recent Patents on Anti-Cancer Drug Discovery 8 154-167. (doi:10.2174/1574892811308020004)
156. Sun X, Casbas-Hernandez P, Bigelow C, Makowski L, Joseph Jerry D, Smith Schneider S & Troester MA 2012 Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression. Breast Cancer Research and Treatment 131 1003-1012. (doi:10.1007/s10549-011-1789-3)
157. Sundaram S, Johnson AR & Makowski L 2013 Obesity, metabolism and the microenvironment: links to cancer. Journal of Carcinogenesis 12 19. (doi:10.4103/1477-3163.119606)
158. Taylor KW, Novak RF, Anderson HA, Birnbaum LS, Blystone C, Devito M, Jacobs D, Kohrle J, Lee DH, Rylander L et al. 2013 Evaluation of the association between persistent organic pollutants (POPs) and diabetes in epidemiological studies: a national toxicology program workshop review. Environmental Health Perspectives 121 774-783. (doi:10.1289/ehp.1205502)
159. Thundiyil JG, Solomon GM & Miller MD 2007 Transgenerational exposures: persistent chemical pollutants in the environment and breast milk. Pediatric Clinics of North America 54 81-101 ix. (doi:10.1016/j.pcl.2006.11.006)
160. Valvi D, Mendez MA, Garcia-Esteban R, Ballester F, Ibarluzea J, Goni F, Grimalt JO, Llop S, Marina LS, Vizcaino E et al. 2014 Prenatal exposure to persistent organic pollutants and rapid weight gain and overweight in infancy. Obesity 22 488-496. (doi:10.1002/oby.20603)
161. Vargo-Gogola T & Rosen JM 2007 Modelling breast cancer: one size does not fit all. Nature Reviews. Cancer 7 659-672. (doi:10.1038/nrc2193)
162. Vonderhaar BK 1988 Regulation of development of the normal mammary gland by hormones and growth factors. Cancer Treatment and Research 40 251-266. (doi:10.1007/978-1-4613-1733-3-12)
163. Walther TC & Farese RV Jr 2009 The life of lipid droplets. Biochimica et Biophysica Acta 1791 459-466. (doi:10.1016/j.bbalip.2008.10.009)
164. Warner M, Eskenazi B, Mocarelli P, Gerthoux PM, Samuels S, Needham L, Patterson D & Brambilla P 2002 Serum dioxin concentrations and breast cancer risk in the Seveso Women's Health Study. Environmental Health Perspectives 110 625-628. (doi:10.1289/ehp.02110625)
165. Weber R, Gaus C, Tysklind M, Johnston P, Forter M, Hollert H, Heinisch E, Holoubek I, Lloyd-Smith M, Masunaga S et al. 2008 Dioxin- and POP-contaminated sites - contemporary and future relevance and challenges: overview on background, aims and scope of the series. Environmental Science and Pollution Research International 15 363-393. (doi:10.1007/s11356-008-0024-1)
166. WHO 2000 Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization Technical Report Series 894 i-xii. 1-253.
167. Whyte MB, Velusamy S & Aylwin SJ 2014 Disease severity and staging of obesity: a rational approach to patient selection. Current Atherosclerosis Reports 16 456. (doi:10.1007/s11883-014-0456-7)
168. Wilcox S, Sharpe PA, Turner-McGrievy G, Granner M & Baruth M 2013 Frequency of consumption at fast-food restaurants is associated with dietary intake in overweight and obese women recruited from financially disadvantaged neighborhoods. Nutrition Research 33 636-646. (doi:10.1016/j.nutres.2013.05.007)
169. Wolff MS, Britton JA, Teitelbaum SL, Eng S, Deych E, Ireland K, Liu Z, Neugut AI, Santella RM & Gammon MD 2005 Improving organochlorine biomarker models for cancer research. Cancer Epidemiology, Biomarkers & Prevention 14 2224-2236. (doi:10.1158/1055-9965.EPI-05-0173)
170. Woodwell GM 1967 Toxic substances and ecological cycles. Scientific American 216 24-31. (doi:10.1038/scientificamerican0367-24)
171. Yu GW, Laseter J & Mylander C 2011 Persistent organic pollutants in serum and several different fat compartments in humans. Journal of Environmental and Public Health 2011 417980. (doi:10.1155/2011/417980)
172. Zaidi N, Lupien L, Kuemmerle NB, Kinlaw WB, Swinnen JV & Smans K 2013 Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids. Progress in Lipid Research 52 585-589. (doi:10.1016/j.plipres.2013.08.005)
173. Zeliger HI 2013a Lipophilic chemical exposure as a cause of cardiovascular disease. Interdisciplinary Toxicology 6 55-62. (doi:10.2478/intox-2013-0010)
174. Zeliger HI 2013b Lipophilic chemical exposure as a cause of type 2 diabetes (T2D). Reviews on Environmental Health 28 9-20. (doi:10.1515/reveh-2012-0031)